109 related articles for article (PubMed ID: 12890304)
1. Lack of effect of mood stabilizers or neuroleptics on GSK-3 protein levels and GSK-3 activity.
Kozlovsky N; Nadri C; Belmaker RH; Agam G
Int J Neuropsychopharmacol; 2003 Jun; 6(2):117-20. PubMed ID: 12890304
[TBL] [Abstract][Full Text] [Related]
2. The effects of neuropsychiatric drugs on glycogen synthase kinase-3 signaling.
Sutton LP; Rushlow WJ
Neuroscience; 2011 Dec; 199():116-24. PubMed ID: 22001305
[TBL] [Abstract][Full Text] [Related]
3. Psychotropic drugs affect Ser9-phosphorylated GSK-3 beta protein levels in rodent frontal cortex.
Kozlovsky N; Amar S; Belmaker RH; Agam G
Int J Neuropsychopharmacol; 2006 Jun; 9(3):337-42. PubMed ID: 16191209
[TBL] [Abstract][Full Text] [Related]
4. Activation of the canonical Wnt pathway by the antipsychotics haloperidol and clozapine involves dishevelled-3.
Sutton LP; Honardoust D; Mouyal J; Rajakumar N; Rushlow WJ
J Neurochem; 2007 Jul; 102(1):153-69. PubMed ID: 17472703
[TBL] [Abstract][Full Text] [Related]
5. Low GSK-3beta in schizophrenia as a consequence of neurodevelopmental insult.
Kozlovsky N; Nadri C; Agam G
Eur Neuropsychopharmacol; 2005 Jan; 15(1):1-11. PubMed ID: 15572268
[TBL] [Abstract][Full Text] [Related]
6. Lithium and valproate act on the GSK-3β signaling pathway to reverse manic-like behavior in an animal model of mania induced by ouabain.
Valvassori SS; Dal-Pont GC; Resende WR; Jornada LK; Peterle BR; Machado AG; Farias HR; de Souza CT; Carvalho AF; Quevedo J
Neuropharmacology; 2017 May; 117():447-459. PubMed ID: 27789311
[TBL] [Abstract][Full Text] [Related]
7. Haloperidol and clozapine differentially regulate signals upstream of glycogen synthase kinase 3 in the rat frontal cortex.
Roh MS; Seo MS; Kim Y; Kim SH; Jeon WJ; Ahn YM; Kang UG; Juhnn YS; Kim YS
Exp Mol Med; 2007 Jun; 39(3):353-60. PubMed ID: 17603289
[TBL] [Abstract][Full Text] [Related]
8. The effects of antipsychotics on beta-catenin, glycogen synthase kinase-3 and dishevelled in the ventral midbrain of rats.
Alimohamad H; Sutton L; Mouyal J; Rajakumar N; Rushlow WJ
J Neurochem; 2005 Oct; 95(2):513-25. PubMed ID: 16144542
[TBL] [Abstract][Full Text] [Related]
9. Cytoprotection by lithium and valproate varies between cell types and cellular stresses.
Lai JS; Zhao C; Warsh JJ; Li PP
Eur J Pharmacol; 2006 Jun; 539(1-2):18-26. PubMed ID: 16678157
[TBL] [Abstract][Full Text] [Related]
10. Lithium- and valproate-induced alterations in circadian locomotor behavior in Drosophila.
Dokucu ME; Yu L; Taghert PH
Neuropsychopharmacology; 2005 Dec; 30(12):2216-24. PubMed ID: 15956996
[TBL] [Abstract][Full Text] [Related]
11. Antipsychotics alter the protein expression levels of beta-catenin and GSK-3 in the rat medial prefrontal cortex and striatum.
Alimohamad H; Rajakumar N; Seah YH; Rushlow W
Biol Psychiatry; 2005 Mar; 57(5):533-42. PubMed ID: 15737669
[TBL] [Abstract][Full Text] [Related]
12. Valproate regulates GSK-3-mediated axonal remodeling and synapsin I clustering in developing neurons.
Hall AC; Brennan A; Goold RG; Cleverley K; Lucas FR; Gordon-Weeks PR; Salinas PC
Mol Cell Neurosci; 2002 Jun; 20(2):257-70. PubMed ID: 12093158
[TBL] [Abstract][Full Text] [Related]
13. The antiapoptotic actions of mood stabilizers: molecular mechanisms and therapeutic potentials.
Chuang DM
Ann N Y Acad Sci; 2005 Aug; 1053():195-204. PubMed ID: 16179524
[TBL] [Abstract][Full Text] [Related]
14. Effects of antipsychotic drugs on BDNF, GSK-3β, and β-catenin expression in rats subjected to immobilization stress.
Park SW; Phuong VT; Lee CH; Lee JG; Seo MK; Cho HY; Fang ZH; Lee BJ; Kim YH
Neurosci Res; 2011 Dec; 71(4):335-40. PubMed ID: 21893111
[TBL] [Abstract][Full Text] [Related]
15. Glycogen Synthase Kinase-3β as a Putative Therapeutic Target for Bipolar Disorder.
Dandekar MP; Valvassori SS; Dal-Pont GC; Quevedo J
Curr Drug Metab; 2018; 19(8):663-673. PubMed ID: 29283064
[TBL] [Abstract][Full Text] [Related]
16. The mood stabilizers lithium and valproate selectively activate the promoter IV of brain-derived neurotrophic factor in neurons.
Yasuda S; Liang MH; Marinova Z; Yahyavi A; Chuang DM
Mol Psychiatry; 2009 Jan; 14(1):51-9. PubMed ID: 17925795
[TBL] [Abstract][Full Text] [Related]
17. Effects of antipsychotic drugs on the expression of synapse-associated proteins in the frontal cortex of rats subjected to immobilization stress.
Seo MK; Lee CH; Cho HY; You YS; Lee BJ; Lee JG; Park SW; Kim YH
Psychiatry Res; 2015 Oct; 229(3):968-74. PubMed ID: 26254796
[TBL] [Abstract][Full Text] [Related]
18. The acute and chronic effects of combined antipsychotic-mood stabilizing treatment on the expression of cortical and striatal postsynaptic density genes.
Tomasetti C; Dell'Aversano C; Iasevoli F; Marmo F; de Bartolomeis A
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jan; 35(1):184-97. PubMed ID: 21055435
[TBL] [Abstract][Full Text] [Related]
19. Lymphocyte Phospho-Ser-9-GSK-3β/Total GSK-3β Protein Levels Ratio Is Not Affected by Chronic Lithium or Valproate Treatment in Euthymic Patients With Bipolar Disorder.
Azab AN; Vainer E; Agam G; Bersudsky Y
J Clin Psychopharmacol; 2017 Apr; 37(2):226-230. PubMed ID: 28106616
[TBL] [Abstract][Full Text] [Related]
20. GSK-3 activity in neocortical cells is inhibited by lithium but not carbamazepine or valproic acid.
Jonathan Ryves W; Dalton EC; Harwood AJ; Williams RS
Bipolar Disord; 2005 Jun; 7(3):260-5. PubMed ID: 15898963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
